Development of the hematopoetic prostaglandin D synthase inhibitor, GSK3350916A, for the treatment of Duchenne muscular dystrophy
Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world
Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world
